Rocket Lab USA Inc. (RKLB) officer Frank Klein filed Form 144 on 09/17/2025, notifying of proposed sale of 4,286 common shares under Rule 144 of the Securities Act. Shares were acquired from issuer via Restricted Stock Units (RSUs) vesting on 08/22/2025, with aggregate market value of $202,492.07 based on outstanding shares of 479,355,713. The transaction uses broker Morgan Stanley Smith Barney LLC, with approximate sale date 09/17/2025 on NASDAQ. Klein relies on a Rule 10b5-1 trading plan adopted 12/13/2024, certifying no undisclosed material adverse information as of plan date. No securities sold by Klein in the past 3 months. This reflects standard executive compensation practice where RSUs vest periodically, allowing liquidity without market timing concerns due to pre-planned 10b5-1 structure.

Minimal impact for RKLB investors; represents routine vesting and sale of small RSU tranche (<<0.001% of shares outstanding) under pre-established 10b5-1 plan, reducing concerns of insider timing. No indication of distress or adverse knowledge. Monitor for patterns in future filings, executive retention, and stock performance amid Rocket Lab's launch cadence and growth trajectory.